Literature DB >> 22511681

Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.

James S Floyd1, Susan R Heckbert, Noel S Weiss, David S Carrell, Bruce M Psaty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22511681      PMCID： PMC3483067          DOI： 10.1001/jama.2012.489

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Cerivastatin and reports of fatal rhabdomyolysis.

Authors:  Judy A Staffa; Jennie Chang; Lanh Green
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

2.  Weighing the benefits of high-dose simvastatin against the risk of myopathy.

Authors:  Amy Egan; Eric Colman
Journal:  N Engl J Med       Date:  2011-06-15       Impact factor: 91.245

3.  Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.

Authors:  Vincent Lo Re; Joseph K Lim; Matthew Bidwell Goetz; Janet Tate; Harini Bathulapalli; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Farah Kidwai; Cynthia Brandt; Zachariah Dorey-Stein; K Rajender Reddy; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-05-27       Impact factor: 2.890

4.  Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis.

Authors:  Susan E Andrade; David J Graham; Judy A Staffa; Stephanie D Schech; Deborah Shatin; Lois La Grenade; Michael J Goodman; Richard Platt; Jerry H Gurwitz; K Arnold Chan
Journal:  J Clin Epidemiol       Date:  2005-02       Impact factor: 6.437

5.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

6.  Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Authors:  Jane Armitage; Louise Bowman; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321
  6 in total
  21 in total

1.  Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Joseph Yeboah; Stefan Sillau; Joseph C Delaney; Michael J Blaha; Erin D Michos; Rebekah Young; Waqas T Qureshi; Robyn McClelland; Gregory L Burke; Bruce M Psaty; David M Herrington
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

2.  On the hypothetical universal use of statins in primary prevention: an observational analysis on low-risk patients and economic consequences of a potential wide prescription rate.

Authors:  Alejandro Macchia; Javier Mariani; Marilena Romero; Fabio Robusto; Vito Lepore; Antonio Dettorre; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2015-02-11       Impact factor: 2.953

3.  Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.

Authors:  E E Abd El-Hakeem; A M Kaki; S A Almazlom; A J Alsayyad
Journal:  Anaesthesist       Date:  2017-03-06       Impact factor: 1.041

4.  Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?

Authors:  Daniel S Streetman; Stephen M Stout
Journal:  CMAJ       Date:  2015-02-02       Impact factor: 8.262

5.  Electronic Health Record (EHR) Abstraction.

Authors:  Amal A Alzu'bi; Valerie J M Watzlaf; Patty Sheridan
Journal:  Perspect Health Inf Manag       Date:  2021-03-15

6.  The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.

Authors:  James S Floyd; Bruce M Psaty
Journal:  Diabetes Care       Date:  2016-11       Impact factor: 19.112

7.  Combining structured and unstructured data to identify a cohort of ICU patients who received dialysis.

Authors:  Swapna Abhyankar; Dina Demner-Fushman; Fiona M Callaghan; Clement J McDonald
Journal:  J Am Med Inform Assoc       Date:  2014-01-02       Impact factor: 4.497

8.  Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.

Authors:  David S Carrell; Scott Halgrim; Diem-Thy Tran; Diana S M Buist; Jessica Chubak; Wendy W Chapman; Guergana Savova
Journal:  Am J Epidemiol       Date:  2014-01-30       Impact factor: 4.897

9.  Use of administrative data to increase the practicality of clinical trials: Insights from the Women's Health Initiative.

Authors:  Garnet L Anderson; Carolyn J Burns; Joseph Larsen; Pamela A Shaw
Journal:  Clin Trials       Date:  2016-06-30       Impact factor: 2.486

10.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Authors:  Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth
Journal:  Circulation       Date:  2015-11-04       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.